How do prescription opioid users differ from users of heroin or other drugs in psychopathology: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
about
Opioid substitution and antagonist therapy trials exclude the common addiction patient: a systematic review and analysis of eligibility criteriaOpioid Use Disorders.Spontaneous reductions in smoking during double-blind buprenorphine detoxification.A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers.Use trajectories of amphetamine-type stimulants (ATS) in Shanghai, China.Advances in opioid antagonist treatment for opioid addiction.Comparing the life concerns of prescription opioid and heroin users.Prescription drug abuse: from epidemiology to public policyAssessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patientsPrescription opioid misuse and mental health among young injection drug users.Lifetime history of heroin use is associated with greater drug severity among prescription opioid abusers.Differences in onset and abuse/dependence episodes between prescription opioids and heroin: results from the National Epidemiologic Survey on Alcohol and Related Conditions.Gender and racial/ethnic differences in addiction severity, HIV risk, and quality of life among adults in opioid detoxification: results from the National Drug Abuse Treatment Clinical Trials Network.Co-occurring amphetamine use and associated medical and psychiatric comorbidity among opioid-dependent adults: results from the Clinical Trials Network.Use of item response theory and latent class analysis to link poly-substance use disorders with addiction severity, HIV risk, and quality of life among opioid-dependent patients in the Clinical Trials Network.Buprenorphine for prescription opioid addiction in a patient with depression and alcohol dependence.Improving public health through access to and utilization of medication assisted treatmentCo-administration of morphine and oxycodone vaccines reduces the distribution of 6-monoacetylmorphine and oxycodone to brain in rats.Buprenorphine Initiation and Linkage to Outpatient Buprenorphine do not Reduce Frequency of Injection Opiate Use Following Hospitalization.Correlates of Opioid Use in Adults With Self-Reported Drug Use Recruited From Public Safety-Net Primary Care Clinics.The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findingsAlcohol Screening among Opioid Agonist Patients in a Primary Care Clinic and an Opioid Treatment ProgramTreatment of prescription opioid disorders in Canada: looking at the 'other epidemic'?Past year non-medical opioid use and abuse and PTSD diagnosis: Interactions with sex and associations with symptom clusters.Disruptive office behaviors in the medical setting: associations with other clinical phenomenaCo-occurring prescription opioid use problems and posttraumatic stress disorder symptom severity.Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START).Type of opioid dependence among patients seeking opioid substitution treatment: are there differences in background and severity of problems?Pain and motives for use among non-treatment seeking individuals with prescription opioid dependenceComparisons of Cocaine-Only, Opioid-Only, and Users of Both Substances in the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).Engagement, retention, and abstinence for three types of opioid users in Florida.Nonmedical prescription drug users in private vs. public substance abuse treatment: a cross sectional comparison of demographic and HIV risk behavior profilesBaseline characteristics and treatment outcomes in prescription opioid dependent patients with and without co-occurring psychiatric disorder.Opiate dependence in schizophrenia: case presentation and literature review.Comparing treatment-seeking codeine users and strong opioid users: Findings from a novel case series.Treatment utilization among persons with opioid use disorder in the United States.Racial/Ethnic Differences in Prevalence Trends for Heroin use and Non-Medical use of Prescription Opioids Among Entrants to Opioid Treatment Programs, 2005-2016.Type of opioids injected: does it matter? A multicentric cross-sectional study of people who inject drugs.Reduced antinociception of opioids in rats and mice by vaccination with immunogens containing oxycodone and hydrocodone haptens.From oxycodone to heroin: two cases of transitioning opioid use in young Australians.
P2860
Q26778626-1D511759-BA7E-4D91-8A02-7625431185F3Q30249393-9A9C8CC4-CE1D-4496-96EB-E4923398ECC2Q33853121-88110713-2533-4D42-BA45-FE5EC01692CEQ34040286-0BD5AB26-791F-4400-9B7E-5796F9422195Q34167524-A974DB6F-D3C8-47B1-BA72-83A65EE516FBQ34262649-DCC8822D-38D3-4C25-8BEC-0B35CA380DA8Q34602734-FEB01B62-B6F0-475F-A101-8C88FD5E42B9Q34603363-AA18E1BD-B32D-4879-9D2D-E1F1B3683314Q34625628-D5EAE00F-78DC-4502-920E-19BD9382E03DQ34674284-2D0FB353-FA79-4601-A347-85DC5C709175Q34749324-F660F8B6-9B09-4D39-A9B1-11A4C0C1DA23Q35043378-3A28A5F2-C65A-47AC-B1B0-19554C78DE16Q35065975-3FA09561-7364-4721-A112-358BCA1E6B75Q35185527-1A0C2BDB-6EC3-4650-BB0E-11BE2CB75CEEQ35206845-5D670BEB-3A32-4B43-BD14-A93DDBD0210AQ35228546-A25E3AAB-F10C-41F9-91CF-5690A11E334CQ35534893-86473FBF-5D9F-443B-B01C-4986248DFC1CQ36024799-C287E466-6390-49D7-A40D-EEF254BF6865Q36080932-C92C1B33-85BB-44FB-B142-BF3F1923A172Q36163633-40EC3F58-9BE0-499C-A3A6-00747DAD88E6Q36200016-A203FA8C-0990-4658-8E83-D76D8C9ACD45Q36543190-410F89ED-1F60-4E6B-811D-C5B554601C73Q36662425-47F948DE-D9C0-4142-A8C0-41EE8958C219Q36730877-8132E4B7-37B0-4F8E-BC86-5F5BBDED42EFQ36802589-1BD32931-4CC5-4975-A6F1-4997594DC899Q36943846-29CB22DF-5355-49CE-9485-EDF9C404C720Q37012628-BB928CF9-BFD1-4B4F-94C0-02EB9F51EE0CQ37084705-C23474A1-F12F-4F23-89A5-83D0411CA4FFQ37107666-BE8C4ACE-E631-4896-9A40-EA3B27F87702Q37396559-0BE3C02B-3180-460D-AA77-6BD901BEA274Q37512389-CDAC0FC7-ACE2-40DE-B650-6ABB34F02082Q37558785-F1CEB06D-8C26-40F7-B199-6EC80E9835F4Q37626594-FAD898BB-93C2-4B84-8E9D-62DB9CB3CFA7Q38267760-F5323C7C-17D3-4516-95B2-59FC501CA2D7Q38302322-7C4C9EAA-0028-4355-83BC-0EAF2AFC3279Q38376069-228EE90D-0C36-4D0F-85F9-AB45C08B966EQ38602295-37058455-B2DF-4D8C-866A-0C2C2BB6B92DQ42687510-5784340B-0EC4-4808-8A59-3FEACCD64382Q42954843-F52DC1BF-6F9B-4F6F-B358-FEF10F517FC9Q43523850-33FBD011-C9CD-4D23-B89B-8288012C9E12
P2860
How do prescription opioid users differ from users of heroin or other drugs in psychopathology: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
How do prescription opioid use ...... lcohol and Related Conditions.
@en
How do prescription opioid use ...... lcohol and Related Conditions.
@nl
type
label
How do prescription opioid use ...... lcohol and Related Conditions.
@en
How do prescription opioid use ...... lcohol and Related Conditions.
@nl
prefLabel
How do prescription opioid use ...... lcohol and Related Conditions.
@en
How do prescription opioid use ...... lcohol and Related Conditions.
@nl
P2093
P2860
P1476
How do prescription opioid use ...... Alcohol and Related Conditions
@en
P2093
Chongming Yang
Dan G Blazer
George E Woody
P2860
P356
10.1097/ADM.0B013E3181E0364E
P50
P577
2011-03-01T00:00:00Z